查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760639

结核病全球市场报告（2025年）

Mycobacterium Tuberculosis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年结核病市场规模将强劲成长。到2029年，该市场规模将达到45.7亿美元，复合年增长率为5.2%。预测期内的成长预计将受到以下因素的推动：全球结核病病患病率的上升、全球抗药性结核病发病率的上升、人们对结核病传播和预防意识的增强、政府为消除结核病而采取的倡议和投入，以及结核病治疗研发的不断增加。预测期内的主要趋势包括结核病诊断技术的发展、快速结核病检测的普及、新型结核病疫苗的推出、耐多药结核病新药物方案的开发以及结核病药物製剂的创新。

预计结核病市场的成长将受到研发投入增加的推动。研发 (R&D) 涉及透过系统的研究和实验创造新知识或改进现有产品、服务和技术。技术的快速进步推动着研发投资的增加，因此需要不断创新才能在全球市场上保持竞争力。研发透过发现能够克服目前治疗方法抗药性的候选药物来提高治疗效果和患者预后，从而为结核病治疗做出贡献。例如，2024 年 3 月，英国政府宣布为 TB REACH 计画提供 500 万美元（400 万英镑）的资金，该计画旨在支持创新策略，以改善中低收入国家对结核病的诊断和治疗。该计划可以为 50 万人提供医疗保健，发现 37,000 例结核病，并挽救超过 15,000 人的生命。因此，增加研发投资将推动结核病市场的成长。

结核病市场中的公司正专注于开发先进的解决方案，例如自动化结核病检测，以提供更快、更准确的诊断。自动化结核病检测是一种诊断工具，它使用自动化系统和先进技术，在最少的人为干预下快速准确地检测结核病细菌和抗药性。例如，2025 年 4 月，美国生技公司 Revvity Inc. 宣布，美国食品药物管理局(FDA) 已核准其 Autopure 2400 液体处理平台和 T-SPOT 结核病检测。 Autopure 2400 平台与 T-SPOT.TB 检测的整合透过实现大容量处理并保持准确性，改善了自动化结核病检测。该平台结合了液体处理和磁性细胞分离技术，每次检测最多可检测 24 个检体，第一天的检测在 3.5 小时内完成，并且只需最少的用户参与。 T-SPOT.TB 检测被 WHO 认可为唯一基于 ELISPOT 的 IGRA，可确保结果可重复，不确定结果更少，减少重新检测的需要，并为免疫力缺乏的患者提供可靠的性能。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场宏观经济情境：包括利率、通货膨胀、地缘政治、贸易战、关税以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球结核病市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球结核病市场：成长率分析
  • 全球结核病市场规模及成长率：实际成果值，2019-2024
  • 全球结核病市场规模及成长率：预测（2024-2029 年、2034 年）
  • 全球结核病市场：总可用市场（TAM）

第六章市场区隔

  • 全球结核病市场依产品类型、实际成果值及预测值，2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂和耗材
  • 软体解决方案
  • 全球结核病市场依诊断方法、实际成果值及预测值，2019-2024 年、2024-2029 年、2034 年
  • 基于文化的诊断
  • 分子诊断
  • 免疫学检测
  • 全球结核病市场依给药途径、实际成果值及预测值（2019-2024 年、2024-2029 年、2034 年）
  • 口服药物
  • 注射
  • 全球结核病市场（按最终用户、实际成果值和预测值）2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断实验室
  • 研究所
  • 全球结核病市场按设备类型、实际成果值和预测值，2019-2024 年、2024-2029 年、2034 年
  • 诊断设备
  • 检测设备
  • 分子诊断设备
  • 结核病培养系统
  • 全球结核病市场按试剂和耗材类型、实际成果值和预测值（2019-2024 年、2024-2029 年和 2034 年）
  • 聚合酵素链锁反应（PCR）试剂
  • 结核菌培养基
  • 抗原试剂套件
  • 测试条
  • 结核病诊断试剂套件
  • 全球结核病市场（按软体解决方案类型、实际成果值和预测值），2019-2024 年、2024-2029 年、2034 年
  • 实验室资讯管理系统（LIMS）
  • 诊断软体
  • 资料管理软体
  • 结核病诊断的远端医疗解决方案

第七章 区域和国家分析

  • 全球结核病市场各地区实际成果值值及预测值（2019-2024、2024-2029、2034）
  • 全球结核病市场（按国家/地区划分）、实际成果值和预测值（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 结核病市场：竞争格局
  • 结核病市场：公司简介
    • F. Hoffmann-La Roche Ltd.（概况、产品与服务、策略、财务分析）
    • 赛默飞世尔科技公司（概况、产品与服务、策略、财务分析）
    • 雅培实验室（概况、产品与服务、策略、财务分析）
    • 诺华公司（概况、产品与服务、策略、财务分析）
    • 碧迪公司（概况、产品与服务、策略、财务分析）

第31章 其他大型创新企业

  • Viatris Inc.
  • Macleods Pharmaceuticals Limited
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • QIAGEN NV
  • Lupin Limited
  • Zydus Cadila Healthcare Limited
  • Cepheid Inc.
  • Serum Institute of India Pvt. Ltd.
  • Oxford Immunotec USA Inc.
  • Panacea Biotec Limited
  • International AIDS Vaccine Initiative Inc.
  • HiMedia Laboratories Private Limited
  • Akonni Biosystems Inc.

第 32 章全球市场：竞争基准化分析板

第33章 重大企业合併（M&A）

第34章近期市场趋势

第35章：具有高市场潜力的国家、产业与策略

  • 结核病市场：提供新机会的国家（2029年）
  • 结核病市场：提供新机会的领域（2029）
  • 结核病市场：成长策略（2029年）
    • 基于市场趋势的策略
    • 竞争策略

第36章 附录

简介目录
Product Code: r35516

Mycobacterium tuberculosis is a slow-growing, rod-shaped bacterium that primarily targets the lungs, although it can also affect other body parts. It is the pathogen responsible for tuberculosis (TB), a contagious disease transmitted through airborne droplets when an infected person coughs, sneezes, or speaks. The bacterium has a distinct, waxy cell wall made of mycolic acid, which provides resistance to drying and helps it persist in the environment.

The primary product types associated with Mycobacterium tuberculosis include instruments, reagents and consumables, and software solutions. Instruments refer to the medical devices and equipment used for diagnosing and researching TB. Diagnosis can be achieved through various techniques, such as culture-based methods, molecular testing, and immunological assays, with administration routes being either oral or injectable. These products are used by various end users, including hospitals, diagnostic labs, and research institutions.

The mycobacterium tuberculosis market research report is one of a series of new reports from The Business Research Company that provides mycobacterium tuberculosis market statistics, including mycobacterium tuberculosis industry global market size, regional shares, competitors with a mycobacterium tuberculosis market share, detailed mycobacterium tuberculosis market segments, market trends and opportunities, and any further data you may need to thrive in the mycobacterium tuberculosis industry. This mycobacterium tuberculosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mycobacterium tuberculosis market size has grown strongly in recent years. It will grow from $3.54 billion in 2024 to $3.74 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to the rising number of TB cases in high-burden countries, increased funding from international organizations, the expansion of TB screening programs, a higher incidence of TB-HIV co-infections, and the growth in global travel and migration, which have contributed to the spread of TB.

The mycobacterium tuberculosis market size is expected to see strong growth in the next few years. It will grow to $4.57 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth during the forecast period is expected to be driven by the increasing prevalence of TB worldwide, the rising global incidence of drug-resistant TB, heightened awareness about TB transmission and prevention, government initiatives and funding for TB elimination, and increased research and development efforts focused on TB treatment. Key trends in the forecast period include advances in TB diagnostic technologies, the availability of rapid TB testing methods, the introduction of new TB vaccines, the development of new drug regimens for multidrug-resistant TB, and technological innovations in TB drug formulation.

The growth of the mycobacterium tuberculosis market is expected to be driven by increased investments in research and development. Research and development (R&D) involves the creation of new knowledge or the improvement of existing products, services, or technologies through systematic investigation and experimentation. The rising investment in R&D is fueled by rapid technological advancements, creating the need for constant innovation to remain competitive in the global market. R&D contributes to mycobacterium tuberculosis treatment by discovering novel drug candidates capable of overcoming resistance to current therapies, thus enhancing treatment efficacy and patient outcomes. For example, in March 2024, the UK government announced a $5 million (£4 million) funding boost for the TB REACH program, aimed at supporting innovative strategies for improving tuberculosis diagnosis and treatment in low- and middle-income countries. This initiative will provide healthcare to 500,000 people, help detect TB in 37,000 individuals, and potentially save more than 15,000 lives. As a result, the increased investment in R&D is set to drive the growth of the mycobacterium tuberculosis market.

Companies in the mycobacterium tuberculosis market are focusing on developing advanced solutions such as automated tuberculosis tests to provide faster, more accurate diagnoses. Automated tuberculosis tests are diagnostic tools that use automated systems and advanced technologies to rapidly and accurately detect Mycobacterium tuberculosis and drug resistance, with minimal human intervention. For instance, in April 2025, Revvity Inc., a US-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) approved the Auto-Pure 2400 liquid handling platform with the T-SPOT TB test. The integration of the Auto-Pure 2400 platform with the T-SPOT.TB test improves automated tuberculosis testing by enabling higher-volume processing while maintaining accuracy. This platform combines liquid handling and magnetic cell isolation technologies, testing up to 24 samples per run, completing Day 1 of testing in under 3.5 hours, and requiring minimal user involvement. The T-SPOT.TB test, recognized by the WHO as the only ELISPOT-based IGRA, ensures reproducible results with fewer indeterminate outcomes, reduces the need for repeat testing, and provides reliable performance for immunocompromised patients.

In November 2023, Becton Dickinson and Company (BD), a US-based provider of tuberculosis diagnostics, collaborated with Bio Farma to help Indonesia eliminate the spread of tuberculosis. This partnership aims to enhance access to BD's innovative TB diagnostics portfolio and improve the TB solutions supply chain in Indonesia. It also offers Bio Farma the opportunity to deepen its expertise in the development of diagnostic kits. Bio Farma is an Indonesia-based manufacturer of tuberculosis vaccines.

Major players in the mycobacterium tuberculosis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Macleods Pharmaceuticals Limited, bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Lupin Limited, Zydus Cadila Healthcare Limited, Cepheid Inc., Serum Institute of India Pvt. Ltd., Oxford Immunotec USA Inc., Panacea Biotec Limited, International AIDS Vaccine Initiative Inc., HiMedia Laboratories Private Limited, and Akonni Biosystems Inc.

North America was the largest region in the mycobacterium tuberculosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mycobacterium tuberculosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mycobacterium tuberculosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mycobacterium tuberculosis market consists of revenues earned by entities by providing services such as tuberculosis strain typing and genotyping services, contract research services, biorepository services, and genomic sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mycobacterium tuberculosis market also includes sales of diagnostic kits, antibodies, antigens, recombinant proteins, nucleic acid extraction kits, and biosafety equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mycobacterium Tuberculosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mycobacterium tuberculosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mycobacterium tuberculosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mycobacterium tuberculosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instruments; Reagents And Consumables; Software Solutions
  • 2) By Diagnostic Method: Culture-Based Methods; Molecular Diagnosis; Immunological Tests
  • 3) By Route Of Administration: Oral; Injectable
  • 4) By End User: Hospitals; Diagnostic Laboratories; Research Institutions
  • Subsegments:
  • 1) By Instruments: Diagnostic Instruments; Detection Instruments; Molecular Diagnostic Instruments; Tuberculosis Culture Systems
  • 2) By Reagents And Consumables: Polymerase Chain Reaction Reagents; Tuberculosis Culture Media; Antigen Kits; Test Strips; Tuberculosis Diagnostic Kits
  • 3) By Software Solutions: Laboratory Information Management Systems (LIMS); Diagnostic Software; Data Management Software; Telemedicine Solutions for TB Diagnosis
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Novartis AG; Becton Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mycobacterium Tuberculosis Market Characteristics

3. Mycobacterium Tuberculosis Market Trends And Strategies

4. Mycobacterium Tuberculosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Mycobacterium Tuberculosis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Mycobacterium Tuberculosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Mycobacterium Tuberculosis Market Growth Rate Analysis
  • 5.4. Global Mycobacterium Tuberculosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Mycobacterium Tuberculosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Mycobacterium Tuberculosis Total Addressable Market (TAM)

6. Mycobacterium Tuberculosis Market Segmentation

  • 6.1. Global Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents And Consumables
  • Software Solutions
  • 6.2. Global Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Culture-Based Methods
  • Molecular Diagnosis
  • Immunological Tests
  • 6.3. Global Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Injectable
  • 6.4. Global Mycobacterium Tuberculosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions
  • 6.5. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Instruments
  • Detection Instruments
  • Molecular Diagnostic Instruments
  • Tuberculosis Culture Systems
  • 6.6. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction Reagents
  • Tuberculosis Culture Media
  • Antigen Kits
  • Test Strips
  • Tuberculosis Diagnostic Kits
  • 6.7. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Information Management Systems (LIMS)
  • Diagnostic Software
  • Data Management Software
  • Telemedicine Solutions for TB Diagnosis

7. Mycobacterium Tuberculosis Market Regional And Country Analysis

  • 7.1. Global Mycobacterium Tuberculosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Mycobacterium Tuberculosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mycobacterium Tuberculosis Market

  • 8.1. Asia-Pacific Mycobacterium Tuberculosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mycobacterium Tuberculosis Market

  • 9.1. China Mycobacterium Tuberculosis Market Overview
  • 9.2. China Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mycobacterium Tuberculosis Market

  • 10.1. India Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mycobacterium Tuberculosis Market

  • 11.1. Japan Mycobacterium Tuberculosis Market Overview
  • 11.2. Japan Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mycobacterium Tuberculosis Market

  • 12.1. Australia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mycobacterium Tuberculosis Market

  • 13.1. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mycobacterium Tuberculosis Market

  • 14.1. South Korea Mycobacterium Tuberculosis Market Overview
  • 14.2. South Korea Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mycobacterium Tuberculosis Market

  • 15.1. Western Europe Mycobacterium Tuberculosis Market Overview
  • 15.2. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mycobacterium Tuberculosis Market

  • 16.1. UK Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mycobacterium Tuberculosis Market

  • 17.1. Germany Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mycobacterium Tuberculosis Market

  • 18.1. France Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mycobacterium Tuberculosis Market

  • 19.1. Italy Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mycobacterium Tuberculosis Market

  • 20.1. Spain Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mycobacterium Tuberculosis Market

  • 21.1. Eastern Europe Mycobacterium Tuberculosis Market Overview
  • 21.2. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mycobacterium Tuberculosis Market

  • 22.1. Russia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mycobacterium Tuberculosis Market

  • 23.1. North America Mycobacterium Tuberculosis Market Overview
  • 23.2. North America Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mycobacterium Tuberculosis Market

  • 24.1. USA Mycobacterium Tuberculosis Market Overview
  • 24.2. USA Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mycobacterium Tuberculosis Market

  • 25.1. Canada Mycobacterium Tuberculosis Market Overview
  • 25.2. Canada Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mycobacterium Tuberculosis Market

  • 26.1. South America Mycobacterium Tuberculosis Market Overview
  • 26.2. South America Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mycobacterium Tuberculosis Market

  • 27.1. Brazil Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mycobacterium Tuberculosis Market

  • 28.1. Middle East Mycobacterium Tuberculosis Market Overview
  • 28.2. Middle East Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mycobacterium Tuberculosis Market

  • 29.1. Africa Mycobacterium Tuberculosis Market Overview
  • 29.2. Africa Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mycobacterium Tuberculosis Market Competitive Landscape And Company Profiles

  • 30.1. Mycobacterium Tuberculosis Market Competitive Landscape
  • 30.2. Mycobacterium Tuberculosis Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Mycobacterium Tuberculosis Market Other Major And Innovative Companies

  • 31.1. Viatris Inc.
  • 31.2. Macleods Pharmaceuticals Limited
  • 31.3. bioMerieux SA
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Bruker Corporation
  • 31.6. QIAGEN N.V.
  • 31.7. Lupin Limited
  • 31.8. Zydus Cadila Healthcare Limited
  • 31.9. Cepheid Inc.
  • 31.10. Serum Institute of India Pvt. Ltd.
  • 31.11. Oxford Immunotec USA Inc.
  • 31.12. Panacea Biotec Limited
  • 31.13. International AIDS Vaccine Initiative Inc.
  • 31.14. HiMedia Laboratories Private Limited
  • 31.15. Akonni Biosystems Inc.

32. Global Mycobacterium Tuberculosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mycobacterium Tuberculosis Market

34. Recent Developments In The Mycobacterium Tuberculosis Market

35. Mycobacterium Tuberculosis Market High Potential Countries, Segments and Strategies

  • 35.1 Mycobacterium Tuberculosis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Mycobacterium Tuberculosis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Mycobacterium Tuberculosis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer